ABC News (3/6, Westman) reports, “The popularity around weight loss drugs…is worrying eating disorder experts, who say the conversation risks making recovery harder and could put others at risk of developing disorders.” Medications including semaglutide injection 0.5 mg, 1 mg, or 2 mg (Ozempic) and tirzepatide (Mounjaro) “were originally developed and FDA approved to treat people with Type 2 diabetes” but they can “also lead to weight loss, and many doctors also prescribe them off-label to patients with obesity.” But now, “celebrities and public figures are either taking or are rumored to take these drugs, as are others who” do not have overweight “but who have the means to pay for a prescription out of pocket.”
Related Links:
— “Eating disorder experts are worried about diabetes drugs like Ozempic being used for weight loss “Nicole Wetsman, ABC News, March 6, 2023